This node is now inactive. (Merged with the Long Island Node to form the Greater New York Node in 2010)
The New York Node is a consortium of academic centers, clinical programs and local and regional agencies with a long track record of fruitful collaboration in research, training, service delivery, policy-making, funding, and advocacy for addictive disorders. Key academic institutions include New York University, The Rockefeller University, the Nathan Kline Institute, and the New York Academy of Medicine. Our CTPs provide a wide range of programs and treatment models, and services for more than 13,000 patients with extensive diagnostic, ethnic, and gender diversity. New York Node CTPs have been at the forefront of translational research and have made a number of pioneering achievements including the establishment of the first outpatient narcotic detoxification clinic, the first non-hospital-based methadone program, the first methadone-to-abstinence residential community, and the first social work field training in addiction.
- A Pilot Study of Osmotic-Release Methylphenidate (OROS-MPH) in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder (ADHD) (CTN-0029)
- Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment (CTN-0016)
- Women's Treatment for Trauma and Substance Use Disorders (CTN-0015)
- Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs (CTN-0009)
- Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics (CTN-0007)
- Motivational Interviewing (MI) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse (CTN-0005)
- Suboxone® (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules (CTN-0003)
- Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Outpatient Opiate Detoxification (CTN-0002)
Get this Publication
Formed with SAMHSA to reduce the gap between research results and treatment.